1. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int.
2008;19:385–97. https://doi.org/10.1007/s00198-007-0543-5.
2. Li L, Wang Z. Ovarian aging and osteoporosis. Adv Exp Med Biol.
2018;1086:199–215. https://doi.org/10.1007/978-981-13-1117-8_13.
3. Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L, Lin
H, Jin X, Dong Z, Ren Z, Hou Z, Zhang Y, Zhong J, Cai S, Liu Y, Meng R, Deng
Y, Ding X, Ma J, Xie Z, Shen L, Wu W, Zhang M, Ying Q, Zeng Y, Dong J, Cummings SR, Li Z, Xia W. Prevalence of osteoporosis and fracture in China: the
China osteoporosis prevalence study. JAMA Netw Open. 2021;4:e2121106.
https://doi.org/10.1001/jamanetworkopen.2021.21106.
4. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO. Fracture
healing in the elderly patient. Exp Gerontol. 2006;41:1080–93. https://doi.
org/10.1016/j.exger.2006.09.008.
5. Duque G, Huang DC, Dion N, Macoritto M, Rivas D, Li W, Yang XF, Li J, Lian
J, Marino FT, Barralet J, Lascau V, Deschênes C, Ste-Marie LG, Kremer R.
Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis
in ovariectomized mice. J Bone Miner Res. 2011;26:1472–83. https://doi.
org/10.1002/jbmr.350.
6. Walsh WR, Sherman P, Howlett CR, Sonnabend DH, Ehrlich MG. Fracture
healing in a rat osteopenia model. Clin Orthop Relat Res. 1997;342:218–27.
https://doi.org/10.1097/00003086-199709000-00029.
7. Shi C, Wu J, Yan Q, Wang R, Miao D. Bone marrow ablation demonstrates that
estrogen plays an important role in osteogenesis and bone turnover via an
antioxidative mechanism. Bone. 2015;79:94–104. https://doi.org/10.1016/j.
bone.2015.05.034.
8. Meyer MH, Meyer RA Jr. Altered expression of mitochondrial genes in
response to fracture in old rats. Acta Orthop. 2006;77:944–51. https://doi.
org/10.1080/17453670610013277.
9. Tatehara S, Miyamoto Y, Takechi M, Momota Y, Yuasa T. Osteoporosis influences the early period of the healing after distraction osteogenesis in a
Kawashima et al. BMC Musculoskeletal Disorders
10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. (2023) 24:200
rat osteoporotic model. J Craniomaxillofac Surg. 2011;39:2–9. https://doi.
org/10.1016/j.jcms.2010.03.001.
Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor
receptor 3 is a negative regulator of bone growth. Cell. 1996;84:911–21.
https://doi.org/10.1016/s0092-8674(00)81069-7.
Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P,
Le Merrer M, Munnich A. Mutations in the gene encoding fibroblast growth
factor receptor-3 in achondroplasia. Nature. 1994;371:252–4. https://doi.
org/10.1038/371252a0.
Kim SJ, Pierce W, Sabharwal S. The etiology of short stature affects the clinical
outcome of lower limb lengthening using external fixation. A systematic
review of 18 trials involving 547 patients. Acta Orthop. 2014;85:181–6. https://
doi.org/10.3109/17453674.2014.899856.
Osawa Y, Matsushita M, Hasegawa S, Esaki R, Fujio M, Ohkawara B, Ishiguro N,
Ohno K, Kitoh H. Activated FGFR3 promotes bone formation via accelerating
endochondral ossification in mouse model of distraction osteogenesis. Bone.
2017;105:42–9. https://doi.org/10.1016/j.bone.2017.05.016.
Su N, Sun Q, Li C, Lu X, Qi H, Chen S, Yang J, Du X, Zhao L, He Q, Jin M, Shen
Y, Chen D, Chen L. Gain-of-function mutation in FGFR3 in mice leads to
decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis. Hum Mol Genet. 2010;19:1199–210. https://doi.org/10.1093/hmg/
ddp590.
Naski MC, Colvin JS, Coffin JD, Ornitz DM. Repression of hedgehog signaling
and BMP4 expression in growth plate cartilage by fibroblast growth factor
receptor 3. Development. 1998;125:4977–88. https://doi.org/10.1242/
dev.125.24.4977.
Fujio M, Yamamoto A, Ando Y, Shohara R, Kinoshita K, Kaneko T, Hibi H, Ueda
M. Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated
skeletal tissue regeneration through the recruitment of endothelial precursors. Bone. 2011;49:693–700. https://doi.org/10.1016/j.bone.2011.06.024.
Gdalevitch M, Kasaai B, Alam N, Dohin B, Lauzier D, Hamdy RC. The effect of
heparan sulfate application on bone formation during distraction osteogenesis. PLoS ONE. 2013;8:e56790. https://doi.org/10.1371/journal.pone.0056790.
Troulis MJ, Coppe C, O’Neill MJ, Kaban LB. Ultrasound: assessment of
the distraction osteogenesis wound in patients undergoing mandibular
lengthening. J Oral Maxillofac Surg. 2003;61:1144–9. https://doi.org/10.1016/
s0278-2391(03)00672-4.
Mishima K, Kitoh H, Ohkawara B, Okuno T, Ito M, Masuda A, Ishiguro N, Ohno
K. Lansoprazole upregulates polyubiquitination of the TNF receptor-associated factor 6 and facilitates Runx2-mediated osteoblastogenesis. EBioMedicine. 2015;2:2046–61. https://doi.org/10.1016/j.ebiom.2015.11.024.
Perrien DS, Nicks KM, Liu L, Akel NS, Bacon AW, Skinner RA, Swain FL, Aronson
J, Suva LJ, Gaddy D. Inhibin a enhances bone formation during distraction osteogenesis. J Orthop Res. 2012;30:288–95. https://doi.org/10.1002/
jor.21501.
Stine KC, Wahl EC, Liu L, Skinner RA, Vanderschilden J, Bunn RC, Montgomery
CO, Suva LJ, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Lumpkin CK
Jr. Cisplatin inhibits bone healing during distraction osteogenesis. J Orthop
Res. 2014;32:464–70. https://doi.org/10.1002/jor.22527.
Ikuta K, Urakawa H, Kozawa E, Hamada S, Ota T, Kato R, Honda H, Kobayashi
T, Ishiguro N, Nishida Y. In vivo heat-stimulus-triggered osteogenesis. Int J
Hyperthermia. 2015;31:58–66. https://doi.org/10.3109/02656736.2014.98866
2.
Page 10 of 10
23. Akagi H, Ochi H, Soeta S, Kanno N, Yoshihara M, Okazaki K, Yogo T, Harada Y,
Amasaki H, Hara Y. A comparison of the process of remodeling of hydroxyapatite/Poly-D/L-lactide and beta-tricalcium phosphate in a loading site.
BioMed Res Int. 2015;730105. https://doi.org/10.1155/2015/730105.
24. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche
H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. Standardized nomenclature,
symbols, and units for bone histomorphometry: a 2012 update of the report
of the ASBMR histomorphometry nomenclature Committee. J Bone Miner
Res. 2013;28:2–17. https://doi.org/10.1002/jbmr.1805.
25. Matsushita M, Kitoh H, Ohkawara B, Mishima K, Kaneko H, Ito M, Masuda A,
Ishiguro N, Ohno K. Meclozine facilitates proliferation and differentiation
of chondrocytes by attenuating abnormally activated FGFR3 signaling in
achondroplasia. PLoS ONE. 2013;8:e81569. https://doi.org/10.1371/journal.
pone.0081569.
26. Matsushita M, Esaki R, Mishima K, Ishiguro N, Ohno K, Kitoh H. Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and
trabecular bone quality in transgenic mice with achondroplasia. Sci Rep.
2017;7:7371. https://doi.org/10.1038/s41598-017-07044-8.
27. Luo Z, Liu M, Sun L, Rui F. Icariin recovers the osteogenic differentiation and
bone formation of bone marrow stromal cells from a rat model of estrogen
deficiency-induced osteoporosis. Mol Med Rep. 2015;12:382–8. https://doi.
org/10.3892/mmr.2015.3369.
28. Biosse Duplan M, Dambroise E, Estibals V, Veziers J, Guicheux J, LegeaiMallet L. An FGFR3-activating mutation in immature murine osteoblasts
affects the appendicular and craniofacial skeleton. Dis Model Mech.
2021;14:dmm048272. https://doi.org/10.1242/dmm.048272.
29. Abzhanov A, Rodda SJ, McMahon AP, Tabin CJ. Regulation of skeletogenic differentiation in cranial dermal bone. Development. 2007;134:3133–44. https://
doi.org/10.1242/dev.002709.
30. Szabova L, Yamada SS, Wimer H, Chrysovergis K, Ingvarsen S, Behrendt
N, Engelholm LH, Holmbeck K. MT1-MMP and type II collagen specify
skeletal stem cells and their bone and cartilage progeny. J Bone Miner Res.
2009;24:1905–16. https://doi.org/10.1359/jbmr.090510.
31. Su N, Li X, Tang Y, Yang J, Wen X, Guo J, Tang J, Du X, Chen L. Deletion of
FGFR3 in osteoclast lineage cells results in increased bone mass in mice by
inhibiting osteoclastic bone resorption. J Bone Miner Res. 2016;31:1676–87.
https://doi.org/10.1002/jbmr.2839.
32. Wang LC, Takahashi I, Sasano Y, Sugawara J, Mitani H. Osteoclastogenic activity during mandibular distraction osteogenesis. J Dent Res. 2005;84:1010–5.
https://doi.org/10.1177/154405910508401108.
33. Guo J, Li W, Wu Y, Jing X, Huang J, Zhang J, Xiang W, Ren R, Lv Z, Xiao J, Guo F.
Meclizine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis partially by upregulating PXR. Front Pharmacol. 2017;8:693. https://
doi.org/10.3389/fphar.2017.00693.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
...